'On consolidated basis
Quarter ended September 2025 compared with Quarter ended September 2024.
Net sales (including other operating income) of Dr Lal Pathlabs has increased 10.66% to Rs 730.6 crore. Operating profit margin has jumped from 30.67% to 30.67%, leading to 10.67% rise in operating profit to Rs 224.10 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 19.28% to 19.41%. Employee cost decreased from 18.78% to 18.09%. Other expenses rose from 31.26% to 31.82%. Selling and administration expenses rose from 14.19% to 14.55%.
Other income rose 13.24% to Rs 24.8 crore. PBIDT rose 10.92% to Rs 248.9 crore. Provision for interest fell 20% to Rs 4.8 crore. Loan funds declined from Rs 198.50 crore as of 30 September 2024 to Rs 156.00 crore as of 30 September 2025. Inventories rose to Rs 50.20 crore as o...
Pleaselogin & subscribe to view the full report.
More Reports
|
|